What is PACS Group's EV / sales?

PACS Group (PACS) reported EV / sales of 1.5× in Q1 2026.

How has PACS Group's EV / sales changed year-over-year?

PACS Group's EV / sales increased by 34.1% year-over-year, from 1.1× to 1.5×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

PACS Group PACS EV / sales

EV / sales at other companies

The Ensign GroupENSG

2.5×+0.5×

Sabra HealthcareSBRA

5.8×+0.1×

Universal Health ServicesUHS

0.9×-0.2×

BrightSpring Health Services, Inc.BTSG

0.7×+0.2×

Encompass Health CorporationEHC

2.1×-0.3×

HCA HealthcareHCA

2×+0.2×

Other financials

Income statement

See full

Revenue$1.4B+11.2%

Gross profit$346.0M+36.5%

Operating income$120.0M+149%

Net income$80.7M+183%

EPS (diluted)$0.50+194%

Balance sheet

See full

Cash & equivalents$273.7M-5.8%

Total debt$3.5B-3.2%

Total equity$1.0B+38.2%

Total assets$5.7B+3.1%

Cash flow

See full

Operating cash flow$236.3M+57.3%

CapEx$21.8M+23.2%

Free cash flow$214.5M+61.9%

Valuation

See full

Market cap$5.79B+189%

Profitability

See full

Gross margin23%+3.7pp

Operating margin7%+4.6pp

Net margin4.5%+3.4pp

FCF margin7.7%—

Returns & leverage

See full

Return on equity27.3%+15.8pp

Debt / equity3.3×-1.4×

Current ratio1×0.0×

Where this comes from

Calculated from PACS Group’s reported figures.

enterprise value/total revenue=1.5×

Based on the most recent quarter.

The official record: PACS Group’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about PACS Group's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PACS Group's EV / sales?: PACS Group (PACS) reported EV / sales of 1.5× in Q1 2026.
How has PACS Group's EV / sales changed year-over-year?: PACS Group's EV / sales increased by 34.1% year-over-year, from 1.1× to 1.5×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.